pargyline has been researched along with Cancer of Pituitary in 1 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| MacLeod, RM | 1 |
| Fontham, EH | 1 |
| Lehmeyer, JE | 1 |
1 other study available for pargyline and Cancer of Pituitary
| Article | Year |
|---|---|
Prolactin and growth hormone production as influenced by catecholamines and agents that affect brain catecholamines.
Topics: Animals; Catecholamines; Depression, Chemical; Dopamine; Female; Growth Hormone; Guanethidine; In Vi | 1970 |